SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?
- PMID: 32965717
- PMCID: PMC7536963
- DOI: 10.1002/ajhb.23504
SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?
Abstract
SARS-CoV-2, the causative agent of COVID-19 pandemic caught the world unawares by its sudden onset in early 2020. Memories of the 1918 Spanish Flu were rekindled raising extreme fear for the virus, but in essence, it was the host and not the virus, which was deciding the outcome of the infection. Age, gender, and preexisting conditions played critical roles in shaping COVID-19 outcome. People of lower socioeconomic strata were disproportionately affected in industrialized countries such as the United States. India, a developing country with more than 1.3 billion population, a large proportion of it being underprivileged and with substandard public health provider infrastructure, feared for the worst outcome given the sheer size and density of its population. Six months into the pandemic, a comparison of COVID-19 morbidity and mortality data between India, the United States, and several European countries, reveal interesting trends. While most developed countries show curves expected for a fast-spreading respiratory virus, India seems to have a slower trajectory. As a consequence, India may have gained on two fronts: the spread of the infection is unusually prolonged, thus leading to a curve that is "naturally flattened"; concomitantly the mortality rate, which is a reflection of the severity of the disease has been relatively low. I hypothesize that trained innate immunity, a new concept in immunology, may be the phenomenon behind this. Biocultural, socioecological, and socioeconomic determinants seem to be influencing the outcome of COVID-19 in different regions/countries of the world.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Understanding the devastating second wave of COVID-19 pandemic in India.Am J Hum Biol. 2021 Nov;33(6):e23671. doi: 10.1002/ajhb.23671. Epub 2021 Sep 1. Am J Hum Biol. 2021. PMID: 34469036 Free PMC article. No abstract available.
-
A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.J Assoc Physicians India. 2023 Sep;71(9):19-27. doi: 10.59556/japi.71.0335. J Assoc Physicians India. 2023. PMID: 38700297
-
SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.Acta Biomed. 2022 Jul 1;93(3):e2022233. doi: 10.23750/abm.v93i3.12265. Acta Biomed. 2022. PMID: 35775779 Free PMC article.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9. Pulmonology. 2021. PMID: 33867315 Free PMC article. Review.
Cited by
-
COVID-19 pandemic and breast cancer management: A retrospective observational clinical study from Pakistan.Ann Med Surg (Lond). 2021 Mar;63:102151. doi: 10.1016/j.amsu.2021.01.099. Epub 2021 Feb 4. Ann Med Surg (Lond). 2021. PMID: 33564461 Free PMC article.
-
Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity.Evol Med Public Health. 2021 Feb 12;9(1):120-130. doi: 10.1093/emph/eoab006. eCollection 2021. Evol Med Public Health. 2021. PMID: 33732461 Free PMC article. Review.
-
Understanding the devastating second wave of COVID-19 pandemic in India.Am J Hum Biol. 2021 Nov;33(6):e23671. doi: 10.1002/ajhb.23671. Epub 2021 Sep 1. Am J Hum Biol. 2021. PMID: 34469036 Free PMC article. No abstract available.
-
Comparative Analysis of Susceptibility and Severity of COVID-19 in Countries from the Eastern and the Western World Till March '21.Microbiol Insights. 2021 Aug 30;14:11786361211041367. doi: 10.1177/11786361211041367. eCollection 2021. Microbiol Insights. 2021. PMID: 34483666 Free PMC article. Review.
-
An after-action review of COVID-19 cases and mitigation measures at US Mission India, March 2020-July 2021.PLOS Glob Public Health. 2025 May 20;5(5):e0003982. doi: 10.1371/journal.pgph.0003982. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40392896 Free PMC article.
References
-
- Abraham, P. , Aggarwal, N. , Babu, G. R. , Barani, S. , Bhargava, B. , Bhatnagar, T. , … Yadav, N. (2020). Laboratory surveillance for SARS‐CoV‐2 in India: Performance of testing & descriptive epidemiology of detected COVID‐19, January 22–April 30, 2020. Indian Journal of Medical Research, 121, 424–437. - PMC - PubMed
-
- Altfeld, M. , & Gale, M., Jr. (2015). Innate immunity against HIV‐1 infection. Nature Immunology, 16, 554–562. - PubMed
-
- Awasthi, A. , & Mavlankar, D. (2020). COVID‐19 in India: An epidemic in congested cities. BMJ Journals‐COVID‐19 Blog. https://blogs.bmj.com/covid-19/2020/06/01/covid-19-in-india-an-epidemic-...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous